Application of artificial liver in immune-related liver injury induced by immune checkpoint inhibitor: case reports and review of the literature

HIGHLIGHTS

• who: Xuewei Li from the University of Pennsylvania, United States have published the research work: Application of artificial liver in immune-related liver injury induced by immune checkpoint inhibitor: Case reports and review of the literature, in the Journal: (JOURNAL) of September/10,/2021
• what: Liver failure caused by immune checkpoint inhibitors can be treated with artificial liver therapy that can significantly improve the liver function and ensure therapeutic effectiveness and safety during anti-tumor treatment.
• how: Pathological immunohistochemical (IHC) results showed that AE1/AE3 (+) Hepatocyte (partial +) AFP GPC-3 (focal +) HSP70 (+) GS . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.